SIA
BIIB icon

Strategic Investment Advisors’s Biogen BIIB Stock Holding History

Strategic Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,694
Closed -$474K – 188
2021
Q1 		$474K Buy
1,694
+34
+2% +$9.17K 0.12% 138
2020
Q4 		$406K Buy
+1,660
New +$428K 0.12% 142

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Strategic Investment Advisors's BIIB Position: Q2 2021 in Review

Strategic Investment Advisors sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,694 shares — an estimated $474K sold.

Strategic Investment Advisors first reported a position in BIIB in Q4 2020 and held it in 2 quarters. The position peaked at $474K in Q1 2021. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Strategic Investment Advisors reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Strategic Investment Advisors sold 1,694 Biogen shares in Q2 2021, an estimated $474K.
  • Strategic Investment Advisors first reported a position in Biogen in Q4 2020 and held it in 2 quarters.
  • Strategic Investment Advisors's Biogen position peaked at $474K in Q1 2021.
  • 1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Strategic Investment Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.